Steven Rowe, MD

Trials

Studies that name Steven Rowe, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:21 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT07432633 · [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

  Blue Earth Diagnostics · recruiting · Colorectal Cancer, Epithelial Ovarian Cancer, Gastric Cancer · principal investigator
• N/A
  NCT04613128 · The PROMISE Pediatric Study 6 to 11 Years Old

  Nicole Hamblett · completed · Cystic Fibrosis, Cystic Fibrosis in Children · principal investigator
• N/A
  NCT04038047 · A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function

  Nicole Hamblett · completed · Cystic Fibrosis · principal investigator
• N/A
  NCT02856100 · Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer

  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Prostate Cancer · principal investigator
• Ph2
  NCT02443688 · EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients

  Celtaxsys, Inc. · completed · Cystic Fibrosis · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:21 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.